Brown Advisory, an investment management company, released its “Brown Advisory Mid-Cap Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The Strategy ...
CHONGQING, CHINA - MAY 04: In this photo illustration, the logo of Axon Enterprise, Inc. is displayed on a smartphone screen, with the company's distinctive black-and-white branding visible in the ...
After getting battered in the second half of 2025 and in early 2026, shares of defense company Axon Enterprise (NASDAQ: AXON) just roared back to life. After reporting its Q4 financial results on Feb.
Axon topped Wall Street's fourth-quarter estimates as new AI capabilities drive more adoption of its software tools. The company is aggressively infusing AI into more technology, including body ...
Feb 25 (Reuters) - Axon Enterprise (AXON.O), opens new tab shares jumped more than 19% in morning trading on Wednesday after the Taser-maker reported fourth-quarter profit above Wall Street ...
Axon Enterprise (AXON) is down 24% year-to-date despite seven consecutive quarters of 30%+ revenue growth. Axon reports Q4 2025 results today. Axon’s Q3 EPS of $1.17 missed estimates by 24% as R&D ...
There was no company-specific news out on Axon last week. Instead, a broader sell-off in high-priced SaaS stocks took down Axon as well. The stock is still expensive at P/S ratio of 16, but the ...
Software & Services revenue grew 39.6% in the first nine months of 2025 and is driving margin expansion. Management raised full-year 2025 revenue guidance to approximately 31% growth despite a Q3 ...
Sun, December 21, 2025 at 3:31 PM UTC Axon (NASDAQ: AXON) has had a turbulent 2025. The stock is flat year to date, down 0.02%, but recent momentum tells a different story. Over the past month, AXON ...
Axon Enterprise offers a compelling long-term growth story, with founder-led vision, high retention rates, and expanding recurring revenue streams. Recent Q3 earnings miss and tariff-driven margin ...
Axon adapted its business model to become a winner. The company continues to evolve, painting an optimistic picture of the future. Many investors are likely familiar with Axon's most famous product, ...